Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia.
Rasheed
A
A
Simpson
J
J
Rosenthal
E
E
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000097:blood; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D005315:Fetal Diseases / Q000097:blood / Q000188:drug therapy*; D005424:Flecainide / Q000009:adverse effects* / Q000097:blood; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy / Q000097:blood; D011295:Prenatal Care; D013617:Tachycardia, Supraventricular / Q000097:blood / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D005424:Flecainide